Article and Video CATEGORIES

Cancer Journey

Search By

Search here for cancer terms and phrases within cancerGRACE.org, and find tons of great information available on the GRACE website.

ABOUT
Howard (Jack) West, MD
Howard Jack West, MD, Founder, Board President

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Read More
Ongoing Great Panel Discussion from the Santa Monica Molecular Markers Webinar: Part 4
Dr West
Author
Howard (Jack) West, MD

Here's the next installment of the panel discussion on molecular markers from the webinar in Santa Monica with Drs. Charlie Rudin, Alice Shaw, David Spigel, and Glen Goss.  We continued our animated discussion on the promise as well as the pitfalls of broadening the use of molecular markers in routine practice of managing patients with advanced NSCLC.

[powerpress]

Below you'll find the audio and video versions of the podcast, along with the transcript (no real figures to go with this one).

Molecular Markers SM Pt 4 Panel Discussion Audio Podcast

Molecular Markers SM Pt 4 Panel Discussion Transcript

We'll continue with a presentation by Dr. Spigel on the value and challenges of incorporating molecular markers into the design of clinical trials in lung cancer.

Tags
ALK Rearrangement
EGFR mutation
FGFR
KRAS mutation
molecular marker
Molecular Oncology
NSCLC
NSCLC histology
patient characteristics
smoking status
Video Language
English

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation

Next Previous link

Previous PostNext Post

Related Content

What is the AVO treatment for Chronic Lymphocytic Leukemia (CLL)? Acalabrutinib, Venetoclax, Obinutuzumab for High-Risk Patients
Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Targeted Therapies 2025
Targeted Therapies in Lung Cancer Patient Forum
Video
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
2025 Foro de Pacientes de Terapias Dirigidas de Cancer de Pulmon
Article
Da click aquí para más información y para registrarte ahora

Forum Discussions

Recent Comments

JOIN THE CONVERSATION
Comparing which scan for swelling above clavicle and near throat - supraclavicular lymph nodes?
Hi Hopish hope,  Welcome to…
By JanineT GRACE … on
Comparing which scan for swelling above clavicle and near throat - supraclavicular lymph nodes?
colon cancer and HIV
By Hopish hope on
Targeted Therapies in Lung Cancer March 2025
Thank you for sharing
By LeviDrake on
Multiple EGFR mutation lung cancer
Hi bluesun,I don't know of…
By JanineT GRACE … on